NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 48 filers reported holding NEOS THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $140,000 | +125.8% | 53,730 | +43.5% | 0.00% | – |
| Q4 2018 | $62,000 | -47.9% | 37,442 | +52.4% | 0.00% | – |
| Q3 2018 | $119,000 | -27.0% | 24,571 | -5.8% | 0.00% | – |
| Q2 2018 | $163,000 | -5.8% | 26,071 | +25.1% | 0.00% | – |
| Q1 2018 | $173,000 | -6.5% | 20,845 | +14.8% | 0.00% | – |
| Q4 2017 | $185,000 | -3.1% | 18,160 | -13.1% | 0.00% | – |
| Q3 2017 | $191,000 | +28.2% | 20,909 | +2.4% | 0.00% | – |
| Q2 2017 | $149,000 | +15.5% | 20,409 | +13.6% | 0.00% | – |
| Q1 2017 | $129,000 | +69.7% | 17,968 | +38.4% | 0.00% | – |
| Q4 2016 | $76,000 | +15.2% | 12,983 | +28.5% | 0.00% | – |
| Q3 2016 | $66,000 | – | 10,105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 693,582 | $4,057,000 | 2.30% |
| DAFNA Capital Management LLC | 38,873 | $227,000 | 0.20% |
| FALCON POINT CAPITAL, LLC | 85,588 | $501,000 | 0.07% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 229,166 | $1,341,000 | 0.06% |
| Cormorant Asset Management, LP | 50,613 | $296,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 14,587 | $85,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 80,000 | $468,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 296,175 | $1,733,000 | 0.00% |
| FRANKLIN RESOURCES INC | 1,315,500 | $7,696,000 | 0.00% |
| COLUMBUS CIRCLE INVESTORS | 42,304 | $247,000 | 0.00% |